Desmond Tutu Hiv Foundation

This study aims to see how well a new, long-acting injectable drug called Lenacapavir works for preventing HIV in real-world settings. It will offer 3700 young people (aged 15-35) in Cape Town a choice between this new injection (given twice a year), another approved injection (g…